https://www.selleckchem.com/pr....oducts/bgj398-nvp-bg
Twenty patients underwent adjuvant radiotherapy with a median follow-up of 12.5 (2-2 years. Of 18 patients who received radiation in a curative setting, one (6%) patient developed thyroid cancer, and one (6%) patient developed sarcoma in the radiation field. This risk for radiation-induced malignancy associated with LFS was higher for both sarcoma and thyroid cancer in comparison with the control cohort. CONCLUSIONS We found a lower risk of radiation-induced secondary malignancies in LFS breast cancer patients than previousl